rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 26

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-01502 · 2009

Thicker Oat Fiber Drinks Release More Satiety Hormones: Viscosity Matters for Fullness

Higher viscosity oat bran beverages produced greater GLP-1 and PYY satiety hormone responses in healthy humans, demonstrating that food physical properties (not just nutrients) affect appetite hormone release.

Juvonen, Kristiina R; Purhonen, Anna-Kaisa; Salmenkallio-Marttila, Marjatta; Lähteenmäki, Liisa; Laaksonen, David E; Herzig, Karl-Heinz; Uusitupa, Matti I J; Poutanen, Kaisa S; Karhunen, Leila J ·

RPEP-01503 · 2009

PYY in Appetite and Obesity: The Complete 2009 Role Review

Updated comprehensive review of PYY3-36's role in appetite regulation and obesity, covering physiology, clinical evidence, therapeutic potential, and challenges including dose-related nausea concerns.

Karra, Efthimia; Chandarana, Keval; Batterham, Rachel L ·

RPEP-01504 · 2009

BPC-157 Reduces Gum Disease Inflammation in Rats

BPC-157 showed anti-inflammatory effects in experimental periodontitis in rats, reducing gingival inflammation and tissue destruction — extending its anti-inflammatory healing to dental/oral applications.

Keremi, B; Lohinai, Z; Komora, P; Duhaj, S; Borsi, K; Jobbagy-Ovari, G; Kallo, K; Szekely, A D; Fazekas, A; Dobo-Nagy, C; Sikiric, P; Varga, G ·

RPEP-01506 · 2009

Gut Cells Release Their Own Opioid Peptides When Tasting Nutrients Through TRPM5 Channels

Duodenal enteroendocrine cells released endogenous opioid peptides (beta-endorphin) in response to nutrients through TRPM5 taste channels — the gut has its own opioid signaling triggered by food tasting at the intestinal level.

Kokrashvili, Zaza; Rodriguez, Deniliz; Yevshayeva, Valeriya; Zhou, Hang; Margolskee, Robert F; Mosinger, Bedrich ·

RPEP-01507 · 2009

GHRP-2 Stimulates Stomach Contractions and Increases Food Intake in Conscious Rats

GHRP-2 increased upper GI contractile activity and food intake in conscious rats through combined hypothalamic and direct gut effects, confirming its dual appetite + motility mechanism for potential gastroparesis treatment.

Kudoh, Katsuyoshi; Shibata, Chikashi; Funayama, Yuji; Fukushima, Kouhei; Ueno, Tatsuya; Hayashi, Keiichi; Inui, Akio; Bowers, Cyril Y; Sasaki, Iwao ·

RPEP-01510 · 2009

Immune Cells Release Opioid Peptides That Protect Against Nerve Pain

Immune cell-derived opioid peptides protected against neuropathic pain in mice, demonstrating that the peripheral immune-opioid system is effective not just for inflammatory pain but also for nerve injury pain.

Labuz, Dominika; Schmidt, Yvonne; Schreiter, Anja; Rittner, Heike L; Mousa, Shaaban A; Machelska, Halina ·

RPEP-01514 · 2009

Lactoferrin and LFchimera Kill the Foodborne Pathogen Vibrio parahaemolyticus

Lactoferrin and the lactoferricin-lactoferrampin chimera (LFchimera) showed bactericidal activity against the halophilic seafood pathogen Vibrio parahaemolyticus — extending milk-derived peptide protection to food safety.

Leon-Sicairos, Nidia; Canizalez-Roman, Adrian; de la Garza, Mireya; Reyes-Lopez, Magda; Zazueta-Beltran, Jorge; Nazmi, Kamran; Gomez-Gil, Bruno; Bolscher, Jan G ·

RPEP-01515 · 2009

Whey Protein Enhances GLP-2's Gut Growth Effects in Malnourished Rats

Whey protein potentiated GLP-2's intestinal growth-promoting effects in parenterally fed rats, demonstrating protein nutrition enhances gut peptide-driven intestinal repair — relevant for malnourished and TPN patients.

Liu, Xiaowen; Murali, Sangita G; Holst, Jens J; Ney, Denise M ·

RPEP-01516 · 2009

A PEG-Modified RGD Peptide Tracer Improves PET Imaging of Tumor Blood Vessels

The new PEG-modified RGD dimer tracer (18F-FP-P-PRGD2) demonstrated enhanced integrin αvβ3 binding affinity compared to the non-PEGylated version (18F-FP-P-RGD2). In U87MG tumor-bearing mice, the PEGylated tracer showed increased tumor uptake and improved tumor-to-background ratios. MicroPET imaging revealed high tumor contrast with low background signal. Biodistribution studies confirmed that uptake was specifically driven by integrin αvβ3 binding. The tracer also successfully imaged integrin expression on activated endothelial cells in a 4T1 murine breast tumor model, demonstrating its ability to visualize tumor neovasculature.

Liu, Zhaofei; Liu, Shuanglong; Wang, Fan; Liu, Shuang; Chen, Xiaoyuan · Preclinical Imaging

RPEP-01520 · 2009

Saturated vs Unsaturated Fat: Different Effects on Satiety Hormones and Appetite

Fat saturation affected satiety hormones differently: saturated fat produced different CCK, GLP-1, and PYY responses than unsaturated fat, with implications for dietary fat type recommendations for appetite management.

Maljaars, Jeroen; Romeyn, Emma A; Haddeman, Edward; Peters, Harry P F; Masclee, Ad A M ·

RPEP-01529 · 2009

NT-proBNP Is More Reliable Than BNP During Natriuretic Peptide Drug Infusion

NT-proBNP more accurately reflected cardiac status during carperitide (ANP analog) infusion than BNP, because BNP levels are directly affected by the drug while NT-proBNP is not — important for monitoring natriuretic peptide therapy.

Nishiyama, Keizo; Tsutamoto, Takayoshi; Tanaka, Toshinari; Fujii, Masanori; Yamamoto, Takashi; Yamaji, Masayuki; Horie, Minoru ·

RPEP-01535 · 2009

VIP Generates Human Transplant-Tolerant Regulatory T-Cells

VIP induced alloantigen-specific human regulatory T-cells that could prevent transplant rejection, advancing neuropeptide-based tolerance induction for organ transplantation.

Pozo, David; Anderson, Per; Gonzalez-Rey, Elena ·

RPEP-01536 · 2009

Urine Peptide Biomarkers That Detect Kidney Transplant Rejection Without a Biopsy

Using label-free LC-MS, researchers detected and quantified approximately 6,000 polypeptide ions in undigested urine from 39 CAD patients and 32 controls. Key findings: - Unsupervised hierarchical clustering of all peptides successfully separated CAD patients from controls - Specific peptides from uromodulin and kininogen were significantly more abundant in controls than CAD patients - Two specific ions (m/z 645.59 and m/z 642.61) differentiated between different forms of CAD with 90% sensitivity and specificity in the training set and ~70% in independent validation - Low uromodulin expression (m/z 638.03) combined with high expression of m/z 642.61 diagnosed CAD in virtually all cases - Results were further validated using multiple reaction monitoring (MRM) experiments

Quintana, Luis F; Campistol, Josep M; Alcolea, Maria P; Bañon-Maneus, Elisenda; Sol-González, Amandaé; Cutillas, Pedro R ·

RPEP-01540 · 2009

Neutrophil-Derived Opioid Peptides Reduce Pain Even Without Inflammation

Neutrophil-released opioid peptides produced pain relief in non-inflamed tissue when triggered by hypertonic stimulation, demonstrating immune-derived opioid analgesia extends beyond inflammatory contexts — broader peripheral pain control.

Rittner, H L; Hackel, D; Yamdeu, R-S; Mousa, S A; Stein, C; Schäfer, M; Brack, A ·

RPEP-01541 · 2009

Bacteria Trigger Neutrophils to Release Opioid Painkillers That Reduce Infection-Related Pain

Mycobacteria activated formyl peptide receptors on neutrophils to release opioid peptides, providing local pain relief during infection — bacteria inadvertently trigger the host's own pain control system.

Rittner, Heike L; Hackel, Dagmar; Voigt, Philipp; Mousa, Shaaban; Stolz, Andrea; Labuz, Dominika; Schäfer, Michael; Schaefer, Michael; Stein, Christoph; Brack, Alexander ·

RPEP-01543 · 2009

Fish Collagen Peptides Improve Cholesterol Profiles in Rats

Collagen hydrolysates from salmon and trout skins improved lipid profiles (reduced LDL, increased HDL) in rats, demonstrating cardiovascular benefits of marine collagen peptides beyond skin/joint health.

Saito, Masataka; Kiyose, Chikako; Higuchi, Tomoyuki; Uchida, Naoyuki; Suzuki, Hiramitsu ·

RPEP-01544 · 2009

New Ghrelin Receptor Antagonists Reduce Appetite and Change Brain Neuron Activity in Rats

Novel GHS-R1A antagonists reduced food intake and altered hypothalamic neuron firing patterns in rats, validating ghrelin receptor blockade as an appetite-suppressing mechanism for obesity drug development.

Salomé, Nicolas; Haage, David; Perrissoud, Daniel; Moulin, Aline; Demange, Luc; Egecioglu, Emil; Fehrentz, Jean-Alain; Martinez, Jean; Dickson, Suzanne L ·

RPEP-01545 · 2009

Smaller Fat Droplets in the Gut Trigger Stronger Satiety Hormone Release

Smaller intraduodenal fat emulsion droplets produced greater CCK and GLP-1 release and stronger appetite suppression in humans, demonstrating that food processing (particle size) determines satiety hormone response.

Seimon, Radhika V; Wooster, Timothy; Otto, Bärbel; Golding, Matthew; Day, Li; Little, Tanya J; Horowitz, Michael; Clifton, Peter M; Feinle-Bisset, Christine ·

RPEP-01546 · 2009

BPC-157 Improves Outcomes in Short Bowel Syndrome in Rats

BPC-157 improved adaptation and outcomes in short bowel syndrome rats, enhancing intestinal adaptation after massive bowel resection — a potential therapy for this devastating surgical condition.

Sever, Marko; Klicek, Robert; Radic, Bozo; Brcic, Luka; Zoricic, Ivan; Drmic, Domagoj; Ivica, Mihovil; Barisic, Ivan; Ilic, Spomenko; Berkopic, Lidija; Blagaic, Alenka Boban; Coric, Marijana; Kolenc, Danijela; Vrcic, Hrvoje; Anic, Tomislav; Seiwerth, Sven; Sikiric, Predrag ·

RPEP-01548 · 2009

ANP Levels Correlate With Heart Chamber Size in Veterinary Cardiac Patients

Plasma ANP concentrations correlated with echocardiographic left atrial and left ventricular dimensions, confirming natriuretic peptides reflect cardiac remodeling in a clinical veterinary/comparative cardiology context.

Sielski, Janusz; Janion, Marianna; Gawor, Zenon; Ciuraszkiewicz, Katarzyna; Sielska, Maria Rebeka ·

RPEP-01549 · 2009

BPC-157 Heals Persistent Gastrocutaneous Fistulas in Rats — A Model for Chronic Wound Healing

BPC-157 healed unhealing gastrocutaneous fistulas in rats, modeling treatment of persistent skin wounds and fistulas — addressing one of surgery's most challenging healing problems.

Skorjanec, Sandra; Dolovski, Zdravko; Kocman, Ivan; Brcic, Luka; Blagaic Boban, Alenka; Batelja, Lovorka; Coric, Marjana; Sever, Marko; Klicek, Robert; Berkopic, Lidija; Radic, Bozo; Drmic, Domagoj; Kolenc, Danijela; Ilic, Spomenko; Cesarec, Vedran; Tonkic, Ante; Zoricic, Ivan; Mise, Stjepan; Staresinic, Mario; Ivica, Mihovil; Lovric Bencic, Martina; Anic, Tomislav; Seiwerth, Sven; Sikiric, Predrag ·

RPEP-01554 · 2009

How DPP-4 Inhibitors Work: Protecting Your Body's Own Blood Sugar-Lowering Peptides

DPP-4 inhibitors work by blocking the enzyme dipeptidyl-peptidase IV, which normally breaks down the incretin hormones GLP-1 and GIP within minutes of their release. By preventing this degradation, DPP-4 inhibitors effectively increase the body's own GLP-1 and GIP levels, leading to improved insulin secretion, reduced glucagon release, and better blood glucose control — all in a glucose-dependent manner that minimizes hypoglycemia risk. The first two approved DPP-4 inhibitors, sitagliptin and vildagliptin, demonstrated good efficacy and tolerability as oral medications for type 2 diabetes. Additional DPP-4 inhibitors were under review or in clinical development at the time of publication.

Thornberry, Nancy A; Gallwitz, Baptist · Review

RPEP-01556 · 2009

Natriuretic Peptides Track Left Atrial Size Changes Over Time in Kidney Failure Patients

Longitudinal natriuretic peptide measurements tracked left atrial volume changes in ESRD patients, with NT-proBNP best reflecting atrial remodeling over time — a non-invasive monitor for cardiac structural changes.

Tripepi, Giovanni; Mattace-Raso, Francesco; Mallamaci, Francesca; Benedetto, Francesco Antonio; Witteman, Jacqueline; Malatino, Lorenzo; Zoccali, Carmine ·